On the day before the 2026 midterm election, the White House issued a press release highlighting drops in prescription drug prices resulting from Donald Trump's policies

Drug pricing and affordability, FDA drug approvals, clinical trial design, drug shortages, insurer coverage, pharmaceutical regulation, and medication access.

Policy, personnel, and politics of the Trump White House.